×
Join our live online event
How top hedge funds use news to make money
form the stock market & how ordinary people are
copying their strategies
Register now!
form the stock market & how ordinary people are
copying their strategies
No thanks
PBM – psyence biomedical ltd. - ordinary shares (US:AMEX)
DELAYED
$
| Volume Shares | |
| 1 Day Range | |
| Volume Ratio | |
| 52 Week High | |
| 52 Week Low |
| VWAP | |
| Today’s Volatility | |
| 20 Days Volatility | |
| Open | |
| Prior Close |
1D
5D
1M
3M
YTD
1Y
3Y
1 Day
PBM
SPY
QQQ
Swipe to see more
Main News & Impact Reports
Date
Time
Symbol
Headline
Impact
11/12
04:30 pm
pbm
Psyence Biomedical Announces Results from Annual and Special General Meeting, Share Consolidation and Receipt of Additional Staff Determination from Nasdaq
High
Report
Psyence Biomedical Announces Results from Annual and Special General Meeting, Share Consolidation and Receipt of Additional Staff Determination from Nasdaq
10/31
09:33 am
pbm
Psyence Group Announces Closing of Previously Announced Disposal of its Stake in PsyLabs [Financial Post (Toronto, Ontario, Canada)]
High
Report
Psyence Group Announces Closing of Previously Announced Disposal of its Stake in PsyLabs [Financial Post (Toronto, Ontario, Canada)]
10/31
09:30 am
pbm
Psyence Group Announces Closing of Previously Announced Disposal of its Stake in PsyLabs
High
Report
Psyence Group Announces Closing of Previously Announced Disposal of its Stake in PsyLabs
10/31
07:30 am
pbm
Psyence Biomedical Announces Closing of Previously Announced Acquisition of Psyence Group’s Stake in PsyLabs
Medium
Report
Psyence Biomedical Announces Closing of Previously Announced Acquisition of Psyence Group’s Stake in PsyLabs
10/25
09:52 am
pbm
Psyence Group's NASDAQ-Listed Associate, Psyence Biomedical, Announces Recruitment of Second Clinical Trial Site for Ongoing Phase IIb Clinical Trial of Nature-Derived Psilocybin for Adjustment Disorder in Palliative Care [Financial Post (Toronto, Ontari
Low
Report
Psyence Group's NASDAQ-Listed Associate, Psyence Biomedical, Announces Recruitment of Second Clinical Trial Site for Ongoing Phase IIb Clinical Trial of Nature-Derived Psilocybin for Adjustment Disorder in Palliative Care [Financial Post (Toronto, Ontari
10/25
09:50 am
pbm
Psyence Group's NASDAQ-Listed Associate, Psyence Biomedical, Announces Recruitment of Second Clinical Trial Site for Ongoing Phase IIb Clinical Trial of Nature-Derived Psilocybin for Adjustment Disorder in Palliative Care [Yahoo! Finance]
Low
Report
Psyence Group's NASDAQ-Listed Associate, Psyence Biomedical, Announces Recruitment of Second Clinical Trial Site for Ongoing Phase IIb Clinical Trial of Nature-Derived Psilocybin for Adjustment Disorder in Palliative Care [Yahoo! Finance]
10/25
09:42 am
pbm
Psyence Group's NASDAQ-Listed Associate, Psyence Biomedical, Announces Recruitment of Second Clinical Trial Site for Ongoing Phase IIb Clinical Trial of Nature-Derived Psilocybin for Adjustment Disorder in Palliative Care
Low
Report
Psyence Group's NASDAQ-Listed Associate, Psyence Biomedical, Announces Recruitment of Second Clinical Trial Site for Ongoing Phase IIb Clinical Trial of Nature-Derived Psilocybin for Adjustment Disorder in Palliative Care
10/24
07:00 am
pbm
Psyence Biomed Announces Recruitment of Second Clinical Trial Site for Ongoing Phase IIb Clinical Trial of Nature-Derived Psilocybin for Adjustment Disorder in Palliative Care
High
Report
Psyence Biomed Announces Recruitment of Second Clinical Trial Site for Ongoing Phase IIb Clinical Trial of Nature-Derived Psilocybin for Adjustment Disorder in Palliative Care
Date
Time
Symbol
Company Name
Action
%Chg
Date
Time
Action
From
To
Firm
Impact
%Chg
Date
Time
Symbol
Headline
Impact
11/13
09:22 am
pbm
Form SC 13G/A PSYENCE BIOMEDICAL LTD. Filed by: Harraden Circle Investments, LLC
High
Report
Form SC 13G/A PSYENCE BIOMEDICAL LTD. Filed by: Harraden Circle Investments, LLC
11/12
05:21 pm
pbm
Form 6-K PSYENCE BIOMEDICAL LTD. For: Nov 12
High
Report
Form 6-K PSYENCE BIOMEDICAL LTD. For: Nov 12
11/12
02:10 pm
pbm
Form SC 13G/A PSYENCE BIOMEDICAL LTD. Filed by: Harraden Circle Investments, LLC
Low
Report
Form SC 13G/A PSYENCE BIOMEDICAL LTD. Filed by: Harraden Circle Investments, LLC
11/12
01:45 pm
pbm
Form SC 13G PSYENCE BIOMEDICAL LTD. Filed by: AdvisorShares Trust
Low
Report
Form SC 13G PSYENCE BIOMEDICAL LTD. Filed by: AdvisorShares Trust
11/12
09:44 am
pbm
Form 424B3 PSYENCE BIOMEDICAL LTD.
Low
Report
Form 424B3 PSYENCE BIOMEDICAL LTD.
11/12
09:19 am
pbm
Form EFFECT PSYENCE BIOMEDICAL LTD.
Medium
Report
Form EFFECT PSYENCE BIOMEDICAL LTD.
11/1
04:08 pm
pbm
Form 6-K PSYENCE BIOMEDICAL LTD. For: Nov 01
Low
Report
Form 6-K PSYENCE BIOMEDICAL LTD. For: Nov 01
10/30
05:04 pm
pbm
Form F-1 PSYENCE BIOMEDICAL LTD.
High
Report
Form F-1 PSYENCE BIOMEDICAL LTD.
Stock Stats
| News Stats | |
|---|---|
| All News | |
| News Wires | |
| Media Monitoring | |
| SEC Edgar Filings | |
| Upgrades | |
| Downgrades | |
| Initiated | |
| Reiterated | |
| Last Earnings | |
| Last Earnings EPS | |
| Next Earnings | |
| Order Stats |
|---|
| Sub-Penny |
|
|
| Odd lot |
|
|
| Avg. bid-ask spread |
|
|
| Avg. bid-ask size |
|
|
| Shares at ask/bid |
|
|
| Off exchange |
|
|
Main News & Impact Reports
TOP News Gainers
TOP News Decliners
Don’t Miss Out On The Next BIG Stock Move
Never get left behind with our daily ‘Shakers & Movers’ newsletter. Discover the biggest gainer or loser in the stock market, and learn exactly WHY it moved. To find out which one caught Wall Street by surprise TODAY, sign up to our newsletter below: